Shanghai OPM Biosciences' low ROE may alarm investors. Yet, ...
Shanghai OPM Biosciences' low ROE may alarm investors. Yet, sharp net income rise, perhaps from management choices or minor payout rate, stands out. High-return reinvestment could be driving its earnings surge.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more